Free Access
Med Sci (Paris)
Volume 22, Number 5, Mai 2006
Page(s) 519 - 524
Section M/S revues
Published online 15 May 2006
  1. Duro D, Bernard O, Della Valle V, et al. A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 1995; 11 : 21–9. [Google Scholar]
  2. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995; 83 : 993–1000. [Google Scholar]
  3. Della Valle V, Duro D, Bernard O, Larsen CJ. The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16INK4a/MTS1 gene. Oncogene 1997; 15 : 2475–81. [Google Scholar]
  4. Pomerantz J, Schreiber-Agus N, Liegeois NJ, et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53. Cell 1998; 92 : 713–23. [Google Scholar]
  5. Llanos S, Clark PA, Rowe J, Peters G. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat Cell Biol 2001; 3 : 445–52. [Google Scholar]
  6. Carnero A, Hudson JD, Price CM, Beach DH. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat Cell Biol 2000; 2 : 148–55. [Google Scholar]
  7. Weber JD, Jeffers JR, Rehg JE, et al. p53-independent functions of the p19ARF tumor suppressor gene. Genes Dev 2000; 14 : 2358–65. [Google Scholar]
  8. Eymin B, Karayan L, Seite P, et al. Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene 2001; 20 : 1033–41. [Google Scholar]
  9. Hannan KM, Hannan RD, Rothblum LI. Transcription by polymerase I. Front Biosci 1998; 3 : 376–98 [Google Scholar]
  10. Russell J, Zomerdijk JC. RNA-polymerase-I-directed rDNA transcription, life and works. Trends Biochem Sci 2005; 30 : 87–96. [Google Scholar]
  11. Voit R, Kuhn A, Sander EE, Grummt I. Activation of mammalian ribosomal gene transcription requires phosphorylation of the nucleolar transcription factor UBF. Nucleic Acids Res 1995; 23 : 2593–9. [Google Scholar]
  12. Grummt I. Regulation of mammalian ribosomal gene transcription by RNA polymerase I. Prog Nucleic Acid Res Mol Biol 1999; 62 : 109–54. [Google Scholar]
  13. Moss T, Stefanovsky VY. At the center of eukaryotic life. Cell 2002; 109 : 545–8. [Google Scholar]
  14. Karayan L, Riou JF, Seite P, et al. Human ARF protein interacts with topoisomerase I and stimulates its activity. Oncogene 2001; 20 : 836–48. [Google Scholar]
  15. Ayrault O, Karayan L, Riou JF, et al. Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I. Oncogene 2003; 22 : 1945–54. [Google Scholar]
  16. Ayrault O, Andrique L, Larsen CJ, Seite P. Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes. Oncogene 2004; 23 : 8097–104. [Google Scholar]
  17. Eymin B, Leduc C, Coll JL, et al. p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene 2003; 22 : 1822–35. [Google Scholar]
  18. Pourquier P, Kohlhagen G, Urasaki Y. Induction of topoisomerase I cleavage complexes by staurosporine in apoptotic leukaemia cells : could topoisomerase I act as an apoptotic endonuclease ? Proc Am Assoc Cancer Res 2001; 42 : 303. [Google Scholar]
  19. Voit R, Schnapp A, Kuhn A, et al. The nucleolar transcription factor mUBF is phosphorylated by casein kinase II in the C terminal hyperacidic tail which is essential for transactivation. EMBO J 1992; 11 : 2211–8. [Google Scholar]
  20. Voit R, Hoffmann M, Grummt I. Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF. EMBO J 1999; 18 : 1891–9. [Google Scholar]
  21. Stefanovsky VY, Pelletier G, Hannan R, et al. An immediate response of ribosomal transcription to growth factor stimulation in mammals is mediated by ERK phosphorylation of UBF. Mol Cell 2001; 8 : 1063–73. [Google Scholar]
  22. Klein J, Grummt I. Cell cycle-dependent regulation of RNA polymerase I transcription : the nucleolar transcription factor UBF is inactive in mitosis and early G1. Proc Natl Acad Sci USA 1999; 96 : 6096–101. [Google Scholar]
  23. Sugimoto M, Kuo ML, Roussel MF, Sherr CJ. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol Cell 2003; 11 : 415–24. [Google Scholar]
  24. Bertwistle D, Sugimoto M, Sherr CJ. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 2004; 24 : 985–96. [Google Scholar]
  25. Itahana K, Bhat KP, Jin A, et al. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell 2003; 12 : 1151–64. [Google Scholar]
  26. Andrique L, Ayrault O, Larsen CJ, Séité P. In vitro and in vivo analysis of the interaction between 5,8S rRNA and ARF protein reveal a new difference between murine p19ARF and human p14ARF. Oncogene 2005; 24 : 2580–4. [Google Scholar]
  27. Zhang Y, Xiong Y. Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ 2001; 12 : 175–86. [Google Scholar]
  28. Piazza F, Gurrieri C, Pandolfi PP. The theory of APL. Oncogene 2001; 20 : 7216–22. [Google Scholar]
  29. Duyster J, Bai RY, Morris SW. Translocations involving anaplastic lymphoma kinase (ALK). Oncogene 2001; 20 : 5623–37. [Google Scholar]
  30. Falini B, mecucci C, Tiacci E, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352 : 254–66. [Google Scholar]
  31. Grisendi S, Pandolfi PP. NPM mutations in acute myelogenous leukemia. N Engl J Med 2005; 352 : 291–2. [Google Scholar]
  32. Den Besten V, Kuo ML, Williams RT, Sherr CJ. Myeloid leukaemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein. Cell Cycle 2005; 4 : 1593–8. [Google Scholar]
  33. Tago K, Chiocca S, Sherr CJ. Sumoylation induced by the Arf tumor suppressor : a p53-independent function. Proc Natl Acad Sci USA 2005; 102 : 7689–94. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.